- Northwest Biotherapeutics Signs Synteract For Management Of Its DCVax(R)-Brain Cancer Phase II
Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT) announced today that it has taken a key step in initiating its Phase II clinical trial to evaluate DCVax(R)-Brain in patients with Glioblastoma multiforme, by awarding the clinical trial management contract to Synteract (Carlsbad, CA). Synteract will perform full service management of the clinical trial. - Two UCSF Faculty Named Fellows Of The American Academy Of Nursing
In recognition of their significant contributions to nursing and health care, Glenna Dowling and Janice Humphreys of the UCSF School of Nursing have been selected as Fellows of the American Academy of Nursing. - An Odd Couple: MGluR4 And Medulloblastoma
Glutamate receptors don't seem like your everyday target for new anti-cancer drugs. However, biology can be stranger than fiction. In this week's Journal, Iacovelli et al. examined the expression of the group III metabotropic glutamate receptor mGluR4, which is normally expressed on various nerve terminals as well as in cerebellar granule cell precursors. - South Dakota Nursing Homes Face Closing, Less Care, Because Of Insufficient Medicaid Funding
South Dakota's 100 nursing homes are projected to lose about $22.62 per Medicaid beneficiary per day this year, according to a recent study by the American Health Care Association, the Sioux Falls Argus Leader reports. The study, conducted by Wisconsin-based accounting company BDO Seidman for the American Health Care Association, indicates that underfunding from the federal government is part of the problem. - Access Worldwide Closes On The Sale Of Pharmaceutical Marketing Operation
Access Worldwide Communications, Inc. (OTC Bulletin Board: AWWC), a leading marketing services organization, today announced that it has closed on the sale of all or substantially all the assets of its Telemanagement Services, Inc. d/b/a TMS Professional Markets Group ("Telemanagement Services") division, to TMS Professional Markets Group, LLC, in a cash transaction valued at $10.5 million. - Nevada Development Authority Launches Campaign In Eastern U.S. Promoting Las Vegas' Pro-Business
The Nevada Development Authority (NDA) is launching an aggressive campaign to recruit businesses from the Eastern region of the U.S. to relocate or expand to Las Vegas. Today's launch will first target businesses in New Jersey, specifically companies in the biotech and life sciences industries. The NDA is approaching New Jersey to capitalize on the rich biotech and life sciences industries in light of the recent budget instability and hindering tax rates. - Report Confirms Aboriginal Death Rates A Continuing Disgrace, Australia
AMA (Australian Medical Association) President, Dr Mukesh Haikerwal, said new research into Aboriginal and Torres Strait Islander death rates confirms Australia must redouble its efforts to improve the health of Indigenous citizens. - Culturally Appropriate Materials Increase Cancer Screening Rates
Colorectal cancer (CRC) screening rates can be significantly improved using a dedicated health educator empowered with culturally appropriate educational tools, according to a new study. Published in the September 1, 2006 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, a randomized, controlled trial found low income Chinese-speaking patients were six-times more likely to be screened for CRC. - Magnetism And Mimicry Of Nature Hold Hope For Better Medicine, Environmental Safety
Critical advances in medicine and environmental protection promise to emerge from a new method for biochemical analysis of fluids developed by an international science team led in part by Arizona State University researchers. - Women Show 47 Percent Greater Persistence With Osteoporosis Drugs If Offered Monthly Tablet, Support
Women who took an osteoporosis drug once a month and received extra telephone support from trained nurses showed 47 per cent greater persistence with their drug treatment than those who took a weekly tablet, according to a study in the August issue of IJCP, the International Journal of Clinical Practice. - Bubbles Go High-tech To Fight Tumors
Bubbles: You've bathed in them, popped them, endured bad song lyrics about them. Now, University of Michigan researchers hope to add a more sophisticated application to the list---gas bubbles used like corks to block oxygen flow to tumors, or to deliver drugs. - Enzyme Inhibitor May Provide Strategy To Treat Some GI Disorders, Jefferson Researchers Find
Drugs that block the activity of an enzyme might hold a key to treating chronic and severe disorders such as certain forms of constipation, hemorrhoids, anal fissures, Hirschsprung's disease and other similar gastrointestinal problems.
|
